Archived explainer. For the current picture see today's SYK page.
Why Is STRYKER CORP (SYK) Stock Down Today?
By the Top Tier Newswire AI Desk · September 8, 2026 at 3:11 PM ET · reviewed against 6 wire stories
STRYKER CORP (SYK) is down -8.89% in the latest session. Our newswire has captured 6 stories on SYK across 5 sources in the last 36 hours, with AI sentiment reading bearish (avg 40/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Stryker Corporation (SYK) stock fell 8.89% to $276.17 in morning trading on concerns over ongoing manufacturing issues and weak performance in key segments. The decline followed comments from Chief Financial Officer Preston Wells, who highlighted continued supply chain challenges and pressure in the vascular and orthopedics segments. The stock has been under pressure for weeks, with a 19.06% drop over the past month and a 28.74% decline in the last 12 months.
What Happened
Stryker’s stock opened at $303.02 but quickly declined throughout the session. The company’s CFO noted that manufacturing issues are preventing the firm from meeting customer demand and securing new business. This commentary, combined with ongoing supply chain disruptions, triggered a sharp sell-off. The stock hit a session low of $275.10 before recovering slightly. The negative sentiment was reinforced by a recent downgrade from Wolfe Research to "Peer Perform." Additionally, Stryker’s recent acquisition of ZuriMED and a new surgical initiative with Apple Vision Pro have not yet offset broader concerns about its core business performance.
What The Data Shows
The stock has traded between $281.00 and $396.86 over the past 52 weeks and currently has a market capitalization of $116.3 billion. The intraday volume of 3.5 million shares is 1.3 times the 3-month daily average, indicating heightened investor activity. Over the last 8 trading sessions, the stock has fallen 14.6% to $279.26. Recent insider transactions show executives selling a combined $118.2 million in shares, while only $27,000 in shares were bought by insiders in the last 90 days. The stock has printed 27 fresh 52-week lows on September 8, 2026.
What To Watch
Stryker does not have an upcoming earnings date listed. Investors should monitor the breadth of coverage and any follow-up analyst commentary as the stock continues to trade near a 33-month low.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
Stryker Corporation (SYK) Wells Fargo 21st Annual Healthcare Conference September 8, 2026 10:15 AM EDTCompany ParticipantsPreston Wells - VP &...
4d agoMorningstarBEARISH 38General
Stryker Stock Declines as Manufacturing Issues Continue
Recent manufacturing issues are "not allowing us to reach a full supply of inventory at all of our customers and quite frankly, not allowing us to go out and really win new business," Chief Financial Officer Preston Wells said during a Wells Fargo conference Tuesday.
4d agoSeeking AlphaBEARISH 34Earnings
Stryker drops after comments on vascular and ortho segments
Stryker (SYK) stock drops, sending rival Zimmer Biomet (ZBH) also lower as CFO warns of continued pressure in vascular and orthopedics segments. Read more here.
Stryker shares decreased to 279.13 USD, the lowest since November 2023. Over the past 4 weeks, Stryker lost 19.06%, and in the last 12 months, it decreased 28.74%.
5d agoStockTitanNEUTRAL 50General
Agilent Announces Retirement of Board Chair Koh Boon Hwee, Appointment of Glenn Boehnlein to Board of Directors
Glenn Boehnlein spent 22 years at Stryker, including as CFO from 2016 to 2025, while Wilson chaired Agilent’s Audit and Finance Committee.
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →